Related Experiment Video
Updated: Jan 30, 2026

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
Published on: September 11, 2018
Calprotectin instability may lead to undertreatment in children with IBD
Sjoukje-Marije Haisma1, Patrick Ferry van Rheenen1, Lucie Wagenmakers2
1Department of Pediatric Gastroenterology, Hepatology and Nutrition, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Insights
Faecal calprotectin is unstable at room temperature, potentially leading to false reassurance in pediatric inflammatory bowel disease (IBD) monitoring. Refrigerating stool samples is crucial for accurate preanalytical handling and reliable IBD management.
Area of Science:
- Biochemistry
- Clinical Diagnostics
- Pediatric Gastroenterology
Background:
- Longitudinal tracking of fecal calprotectin (FC) aids treatment decisions in pediatric inflammatory bowel disease (IBD).
- Limited data exists on the stability of fecal calprotectin during preanalytical sample handling.
- Accurate FC measurements are vital for effective IBD management in children.
Purpose of the Study:
- To evaluate the stability of fecal calprotectin in stool samples under different storage conditions.
- To determine the impact of room temperature versus refrigeration on fecal calprotectin concentrations.
- To assess calprotectin stability in assay-specific extraction buffers.
Main Methods:
- Homogenized stool aliquots were stored at room temperature and 4°C for 6 days.
- Calprotectin concentration was measured daily using three distinct assays.
- Stability was also assessed in assay-specific extraction buffers at room temperature.
Main Results:
- Fecal calprotectin showed significant degradation at room temperature, with mean percentage changes of 35% in stool and 46% in extraction buffer after 6 days.
- Calprotectin stability was significantly better preserved in samples stored at 4°C (p=0.0066 for stool, p=0.0011 for buffer).
- Assay-specific buffers did not fully preserve calprotectin at room temperature.
Conclusions:
- Fecal calprotectin is not stable when stored at room temperature.
- Inaccurate low calprotectin values due to degradation may mislead clinicians and families managing pediatric IBD.
- Refrigeration of stool samples until laboratory delivery is the recommended preanalytical standard for maintaining calprotectin integrity.
Background:
Treatment decisions in children with inflammatory bowel disease (IBD) are increasingly based on longitudinal tracking of faecal calprotectin concentrations, but there is little known about the stability of this protein in stool.
Methods:
We stored aliquots of homogenised stool at room temperature and at 4°C, and measured the calprotectin concentration for 6 consecutive days with three different assays. In addition, we assessed calprotectin stability in assay-specific extraction buffers kept at room temperature.
Results:
After 6 days of storage at room temperature, mean percentage change from baseline calprotectin concentrations in stool and extraction buffer was 35% and 46%, respectively. The stability of calprotectin was significantly better preserved in samples stored at 4°C (p=0.0066 and 0.0011, respectively).
Conclusions:
Calprotectin is not stable at room temperature. Children with IBD and their caretakers may be falsely reassured by low calprotectin values. The best advisable standard for preanalytical calprotectin handling is refrigeration of the stool sample until delivery at the hospital laboratory.
Related Concept Videos
Microtubule Instability
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Phase-lead and Phase-lag Controllers
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drug Dosing: Infants and Children

